Amidst Setbacks, Lacutamab Cleared to Advance in CTCL Phase 3 Trial by FDA

1. Innate Pharma announces FDA clearance to proceed with TELLOMAK 3, a confirmatory phase 3 trial of lacutamab in CTCL. News release. · 2. IPH4102 …